The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Research Report 2025
Synopsis
Treatment of ANUG is by removal of dead gum tissue and antibiotics (usually metronidazole) in the acute phase, and improving oral hygiene to prevent recurrence. Although the condition has a rapid onset and is debilitating, it usually resolves quickly and does no serious harm.
The global Necrotizing Ulcerative Gingivitis (NUG) Treatment market was valued at US$ 6359 million in 2023 and is anticipated to reach US$ 10530 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Necrotizing Ulcerative Gingivitis (NUG) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Necrotizing Ulcerative Gingivitis (NUG) Treatment.
Report Scope
The Necrotizing Ulcerative Gingivitis (NUG) Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Necrotizing Ulcerative Gingivitis (NUG) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Necrotizing Ulcerative Gingivitis (NUG) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Teva Pharmaceutical
Mylan
Sanofi
GlaxoSmithKline
Merck
Otsuka Pharmaceutical
Abbott Laboratories
Eli Lilly and Company
Hindustan Antibiotics
Segment by Type
Medication
Surgery
Segment by Application
Hospitals
Homecare
Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Necrotizing Ulcerative Gingivitis (NUG) Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Treatment of ANUG is by removal of dead gum tissue and antibiotics (usually metronidazole) in the acute phase, and improving oral hygiene to prevent recurrence. Although the condition has a rapid onset and is debilitating, it usually resolves quickly and does no serious harm.
The global Necrotizing Ulcerative Gingivitis (NUG) Treatment market was valued at US$ 6359 million in 2023 and is anticipated to reach US$ 10530 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Necrotizing Ulcerative Gingivitis (NUG) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Necrotizing Ulcerative Gingivitis (NUG) Treatment.
Report Scope
The Necrotizing Ulcerative Gingivitis (NUG) Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Necrotizing Ulcerative Gingivitis (NUG) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Necrotizing Ulcerative Gingivitis (NUG) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Teva Pharmaceutical
Mylan
Sanofi
GlaxoSmithKline
Merck
Otsuka Pharmaceutical
Abbott Laboratories
Eli Lilly and Company
Hindustan Antibiotics
Segment by Type
Medication
Surgery
Segment by Application
Hospitals
Homecare
Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Necrotizing Ulcerative Gingivitis (NUG) Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Medication
1.2.3 Surgery
1.3 Market by Application
1.3.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Perspective (2019-2030)
2.2 Necrotizing Ulcerative Gingivitis (NUG) Treatment Growth Trends by Region
2.2.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Necrotizing Ulcerative Gingivitis (NUG) Treatment Historic Market Size by Region (2019-2024)
2.2.3 Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size by Region (2025-2030)
2.3 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Dynamics
2.3.1 Necrotizing Ulcerative Gingivitis (NUG) Treatment Industry Trends
2.3.2 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Drivers
2.3.3 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Challenges
2.3.4 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Necrotizing Ulcerative Gingivitis (NUG) Treatment Players by Revenue
3.1.1 Global Top Necrotizing Ulcerative Gingivitis (NUG) Treatment Players by Revenue (2019-2024)
3.1.2 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue
3.4 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Concentration Ratio
3.4.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue in 2023
3.5 Necrotizing Ulcerative Gingivitis (NUG) Treatment Key Players Head office and Area Served
3.6 Key Players Necrotizing Ulcerative Gingivitis (NUG) Treatment Product Solution and Service
3.7 Date of Enter into Necrotizing Ulcerative Gingivitis (NUG) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Necrotizing Ulcerative Gingivitis (NUG) Treatment Breakdown Data by Type
4.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Historic Market Size by Type (2019-2024)
4.2 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size by Type (2025-2030)
5 Necrotizing Ulcerative Gingivitis (NUG) Treatment Breakdown Data by Application
5.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Historic Market Size by Application (2019-2024)
5.2 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2019-2030)
6.2 North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2019-2024)
6.4 North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2019-2030)
7.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2019-2024)
7.4 Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2019-2030)
8.2 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2019-2030)
9.2 Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2019-2024)
9.4 Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2019-2030)
10.2 Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
11.1.4 Novartis Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Teva Pharmaceutical
11.2.1 Teva Pharmaceutical Company Detail
11.2.2 Teva Pharmaceutical Business Overview
11.2.3 Teva Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
11.2.4 Teva Pharmaceutical Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
11.2.5 Teva Pharmaceutical Recent Development
11.3 Mylan
11.3.1 Mylan Company Detail
11.3.2 Mylan Business Overview
11.3.3 Mylan Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
11.3.4 Mylan Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
11.3.5 Mylan Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
11.4.4 Sanofi Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
11.6.4 Merck Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
11.6.5 Merck Recent Development
11.7 Otsuka Pharmaceutical
11.7.1 Otsuka Pharmaceutical Company Detail
11.7.2 Otsuka Pharmaceutical Business Overview
11.7.3 Otsuka Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
11.7.4 Otsuka Pharmaceutical Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
11.7.5 Otsuka Pharmaceutical Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Detail
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
11.8.4 Abbott Laboratories Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
11.8.5 Abbott Laboratories Recent Development
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Detail
11.9.2 Eli Lilly and Company Business Overview
11.9.3 Eli Lilly and Company Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
11.9.4 Eli Lilly and Company Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
11.9.5 Eli Lilly and Company Recent Development
11.10 Hindustan Antibiotics
11.10.1 Hindustan Antibiotics Company Detail
11.10.2 Hindustan Antibiotics Business Overview
11.10.3 Hindustan Antibiotics Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
11.10.4 Hindustan Antibiotics Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
11.10.5 Hindustan Antibiotics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Medication
Table 3. Key Players of Surgery
Table 4. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Region (2019-2024)
Table 8. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Region (2025-2030)
Table 10. Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Trends
Table 11. Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Drivers
Table 12. Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Challenges
Table 13. Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Restraints
Table 14. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Players (2019-2024)
Table 16. Global Top Necrotizing Ulcerative Gingivitis (NUG) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment as of 2023)
Table 17. Ranking of Global Top Necrotizing Ulcerative Gingivitis (NUG) Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Necrotizing Ulcerative Gingivitis (NUG) Treatment Product Solution and Service
Table 21. Date of Enter into Necrotizing Ulcerative Gingivitis (NUG) Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Novartis Company Detail
Table 47. Novartis Business Overview
Table 48. Novartis Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 49. Novartis Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. Teva Pharmaceutical Company Detail
Table 52. Teva Pharmaceutical Business Overview
Table 53. Teva Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 54. Teva Pharmaceutical Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024) & (US$ Million)
Table 55. Teva Pharmaceutical Recent Development
Table 56. Mylan Company Detail
Table 57. Mylan Business Overview
Table 58. Mylan Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 59. Mylan Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024) & (US$ Million)
Table 60. Mylan Recent Development
Table 61. Sanofi Company Detail
Table 62. Sanofi Business Overview
Table 63. Sanofi Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 64. Sanofi Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. GlaxoSmithKline Company Detail
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 69. GlaxoSmithKline Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Merck Company Detail
Table 72. Merck Business Overview
Table 73. Merck Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 74. Merck Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024) & (US$ Million)
Table 75. Merck Recent Development
Table 76. Otsuka Pharmaceutical Company Detail
Table 77. Otsuka Pharmaceutical Business Overview
Table 78. Otsuka Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 79. Otsuka Pharmaceutical Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024) & (US$ Million)
Table 80. Otsuka Pharmaceutical Recent Development
Table 81. Abbott Laboratories Company Detail
Table 82. Abbott Laboratories Business Overview
Table 83. Abbott Laboratories Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 84. Abbott Laboratories Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024) & (US$ Million)
Table 85. Abbott Laboratories Recent Development
Table 86. Eli Lilly and Company Company Detail
Table 87. Eli Lilly and Company Business Overview
Table 88. Eli Lilly and Company Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 89. Eli Lilly and Company Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024) & (US$ Million)
Table 90. Eli Lilly and Company Recent Development
Table 91. Hindustan Antibiotics Company Detail
Table 92. Hindustan Antibiotics Business Overview
Table 93. Hindustan Antibiotics Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 94. Hindustan Antibiotics Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024) & (US$ Million)
Table 95. Hindustan Antibiotics Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Type: 2023 VS 2030
Figure 3. Medication Features
Figure 4. Surgery Features
Figure 5. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Homecare Case Studies
Figure 9. Pharmacies Case Studies
Figure 10. Others Case Studies
Figure 11. Necrotizing Ulcerative Gingivitis (NUG) Treatment Report Years Considered
Figure 12. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Region: 2023 VS 2030
Figure 15. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Players in 2023
Figure 16. Global Top Necrotizing Ulcerative Gingivitis (NUG) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue in 2023
Figure 18. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Country (2019-2030)
Figure 20. United States Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Country (2019-2030)
Figure 24. Germany Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Region (2019-2030)
Figure 32. China Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Country (2019-2030)
Figure 40. Mexico Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Country (2019-2030)
Figure 44. Turkey Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Novartis Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
Figure 47. Teva Pharmaceutical Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
Figure 48. Mylan Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
Figure 49. Sanofi Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
Figure 51. Merck Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
Figure 52. Otsuka Pharmaceutical Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
Figure 53. Abbott Laboratories Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
Figure 54. Eli Lilly and Company Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
Figure 55. Hindustan Antibiotics Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
